A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The purpose of this clinical trial is to learn if the study medicine (called PF-07976016) is safe and how it goes in and out of the body in healthy people. The study may also explore if PF-07976016 has the potential to interact with another medicine called midazolam. In addition, the study may explore how PF-07976016 goes into the body of people who have obesity.
Key facts
- Study ID
- NCT06106009
- Run by
- Pfizer
- People needed
- 117
- Starts
- 2023-10-27
- Expected to finish
- 2024-08-19
- Last updated by the study team
- 2024-09-23
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.